[Focal hemorrhagic chorioiditis (author's transl)].
The clinical and fluorescenzangiographic followup of 111 patients revealed, that focal hemorrhagic chorioiditis is a chronic disease with poor prognosis for visual acuity. After a median follow-up period of more than two years, only half of all involved eyes showed inactive scarring of the lesions. In 13% both eyes were involved. Corticosteroids, antiphlogistics and vasoactive drugs had no significant influence on the course of the disease. The therapeutic results with photocoagulation were more favorable. In 15 of 25 photocoagulated eyes a fast and permanent regression of the choroidal proliferations could be achieved.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002833:Choroiditis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005451:Fluorescein Angiography; D006801:Humans; D008875:Middle Aged; D012166:Retinal Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D014792:Visual Acuity
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents
Die fokale hämorrhagische Chorioiditis. Eine klinische und fluoreszenzangiographische Verlaufsstudie